Anti-obesity drugs for the gastroenterologists

This podcast focusses on the Frontline Gastroenterology review paper on anti-obesity medications, authored by Dr Lisa Sharkey. From GLP1-RA GI side effects to nutritional risks, MASLD management and endoscopy considerations — this is a must-listen for every practicing and trainee gastroenterologist navigating the metabolic medicine revolution. Read the manuscript on this link: Anti-obesity drugs for the gastroenterologists We hope you enjoy the #FGPodcast. Please follow @‌FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229

Om Podcasten

The Frontline Gastroenterology (FG) podcast offers in-depth interviews with renowned authors and leading experts in gastroenterology, hepatology and clinical nutrition delving into the best practices in the field. FG - fg.bmj.com - is an esteemed international journal from the BMJ Group and the British Society of Gastroenterology (BSG). Elevate your practice by subscribing to the FG podcast. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.